Identifying ROCK2 as an intervention target for bilirubin encephalopathy

Bingbing Ke1, Linfei Mao1, Mu Hu2

  • 1Shanghai Key Laboratory of Sleep Disordered Breathing, Department of Otolaryngology-Head and Neck Surgery, Otolaryngology Institute of Shanghai JiaoTong University, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

Fundamental Research
|August 1, 2026
PubMed
Summary

Bilirubin encephalopathy causes brain damage. This study identifies Rho-associated protein kinase 2 (ROCK2) as a key player, showing ROCK2 inhibition protects against neuronal damage and improves hearing and cognition in models.